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T he K V 4 subfamily of voltage-gated K
ϩ channels underlies the A-type currents in neuronal tissue (I A ) 1 and the fast-inactivating transient-outward current in the heart (I to,f ). 2 The K ϩ channel interacting proteins (KChIPs) were discovered as a family of four alternatively spliced accessory subunits for the A-type K ϩ currents in neuronal tissue. 3, 4 Whereas all KChIPs are expressed in brain, 3, 4 only KChIP2 is found in heart, where it interacts with K V 4.2 and K V 4.3 to form the native I to,f . 5, 6 K V 4 subunits colocalize with all KChIP subtypes when expressed in cell lines, and the addition of any KChIP increases the K V 4 current density. 7, 8 Furthermore, KChIP1, KChIP2, and KChIP3 slow K V current inactivation and speed recovery from inactivation. 3, 5, 9 KChIP4 has been described as an inactivation suppressor of the K V 4 current, where it abolishes fast inactivation. 10 The KChIPs are neuronal calcium sensor proteins 11 and contain 4 Ca 2ϩ -binding EF-hand motifs, of which the last 3 bind Ca 2ϩ . 3 EF-hand mutations that ablate Ca 2ϩ binding disrupt K ϩ channel modulation but preserve binding affinity to K V 4. 3 Neuronal calcium sensor proteins and KChIPs share structural homology with the superfamily of Ca 2ϩ -binding proteins (CaBP), 12, 13 several of which regulate I Ca,L in the heart. Most prominently, calmodulin (CaM) 14 -17 and CaBP1 18 differentially govern Ca 2ϩ -dependent inactivation of I Ca,L via interactions with the amino (N) or carboxyl (C) termini of the pore-forming ␣ 1C subunit Ca V 1.2. Other members of the CaBP superfamily variously affect different L-type Ca 2ϩ channels (eg, Ca V 1.3) 19, 20 or non-L-type Ca 2ϩ channels (eg, Ca V 2.1), 21 suggesting an extensive interplay among various Ca 2ϩ channels and CaBPs. Whether KChIP2 regulates Ca 2ϩ channels has not been explored, although emerging evidence implicates KChIP2 as a modulator of channels other than K V 4, particularly in the heart. For example, in cell lines KChIP2 impairs trafficking of K V 1.5, 22 and KChIP2 silencing has been reported to eliminate the sodium current (I Na ) in cultured neonatal cardiomyocytes. 23 Thus, in the present study, we hypothesized that KChIP2 modulates the L-type Ca 2ϩ current. Using both ventricular myocytes and a heterologous expression system, we show that KChIP2 increases I Ca,L . Furthermore, biophysical and functional experiments show that KChIP2 binds specifically to the N-terminal inhibitory (NTI) domain of Ca V 1.2 in a Ca 2ϩ -independent manner. This KChIP2-NTI association causes an increase in the Ca 2ϩ current density, independent of protein synthesis and trafficking.
Materials and Methods

Electrophysiological Recordings in Disaggregated Ventricular Myocytes
We studied adult (10 to 12 weeks), male C57BL6 wild-type (WT) and rederived KChIP2 Ϫ/Ϫ mice. 24 All animal experiments were approved by the Institutional Animal Care and Use Committee and conformed to the Guide for the Care and Use of Laboratory Animals (NIH). Genotyping was performed using DNA isolated from tail samples, followed by PCR amplification of KChIP2 and neomycin. ECGs obtained from anesthetized WT and KChIP2 Ϫ/Ϫ mice ( Figure I in the online data supplement, available at http://circres.ahajournals.org) showed ST segment elevation specific to the KChIP2 Ϫ/Ϫ mice, consistent with earlier reports from the KChIP2 Ϫ/Ϫ mice originally generated in the 129SV background. 24 Hearts were excised from anesthetized (0.1 mg/g ketamine, 0.01 mg/g xylazine, IP) mice, and myocytes were disaggregated from the left ventricular free wall. Membrane recordings were made within 6 hours of myocyte isolation using standard whole-cell voltage-clamp protocols. Patch pipettes (1 to 2 M⍀) contained (in mmol/L): 80 aspartic acid, 10 NaCl, 70 CsOH, 40 CsCl, 2 MgCl 2 , 10 EGTA, 10 HEPES-Na, 2 ATP-Na 2 , and 0.1 GTP-Na 2 (pH 7.2). Cells were superfused with (in mmol/L): 135 NaCl, 10 CsCl, 1 CaCl 2 , 1 MgCl 2 , 5 HEPES-Na, 10 dextrose, and 0.01 tetrodotoxin (pH 7.4; 37°C). Current-voltage curves were generated as nifedipine-sensitive (5 mol/L) difference currents using 400-ms depolarizing steps from a holding potential of Ϫ40 mV as described. 25 Currents are expressed as peak inward density; cell capacitances were similar for WT and KChIP2 Ϫ/Ϫ myocytes.
Molecular Biology
cDNA constructs consisted of rabbit ␣ 1C (Ca V 1.2), and rat Ca V ␤ 2 , Ca V ␣ 2 ␦ 2 , and green fluorescent protein (GFP)/KChIP2b (coexpressed via an internal ribosomal entry site) or GFP in pcDNA3.1. The ⌬NT-Ca V 1.2 (amino acids 140 to 2171), and KChIP2-⌬EF (Asp residues at position 1 in EF-hands 2, 3, and 4 of KChIP2b mutated to Ala) were generated by standard molecular biology techniques. The GFP-␣ 1C construct was constructed as previously described. 26 2 . Expressed currents were recorded using 400-ms depolarizing steps to Ϫ40 to ϩ60 mV from a holding potential of Ϫ90 mV.
Electrophysiological Recordings in tsA201 Cells
Protein Chemistry
Immunoblotting was performed using previously described methods. 27 Briefly, whole-cell protein lysates were obtained from WT and KChP2 Ϫ/Ϫ ventricular tissue and from transfected tsA201 cells. Myocardial protein lysates were fractionated using a protocol from Ventura et al. 28 Proteins were separated on 4% to 20% gradient SDS-PAGE gels and transferred to poly(vinylidene difluoride) membranes. Blots were probed with primary antibodies against Ca V 1.2 (NeuroMab, Davis, Calif), GAPDH, or actin (Santa Cruz Biotechnology, Santa Cruz, Calif). Fusion proteins (glutathione S-transferase [GST]-tagged N terminus and His 6 -tagged C terminus) were coexpressed with KChIP2 and purified as described earlier. 29 
Statistical Analysis
Data are expressed as meansϮSEM. One-way ANOVA followed by Bonferroni's t test, when appropriate, was used for statistical comparison. PϽ0.05 was considered statistically significant. Ϫ/Ϫ , a 28% reduction. There were no changes in I Ca,L activation or steady-state inactivation ( Figure 1B ). The decreased current amplitude in KChIP2 Ϫ/Ϫ myocytes was associated with slower Ca 2ϩ -dependent inactivation. The decay phase of the current trace was best fit with 2 exponentials. At voltage steps to ϩ10 mV, fast and slow for WT myocytes were 10Ϯ1 and 61Ϯ10 ms, respectively, compared with 13Ϯ1 ms (PϽ0.05) and 81Ϯ5 ms (Pϭ0.07), respectively, for KChIP2 Ϫ/Ϫ myocytes. The reduced I Ca,L could not be explained by less Ca V 1.2 protein; rather, we found a 64% increase in Ca V 1.2 protein in whole-cell lysates from KChIP2 Ϫ/Ϫ ventricular tissue, compared to WT (PϽ0.05; Figure 1C ). When we partitioned protein lysates from WT and KChIP2 Ϫ/Ϫ ventricles into cytosolic, light membrane (including the plasma membrane), heavy membrane (including the sarcoplasmic reticulum), and debris (predominantly nuclei) fractions, we observed significantly more Ca V 1.
Results
Mice
2-immunoreactive protein in all KChIP2
Ϫ/Ϫ fractions ( Figure 1D ), suggesting that the decreased I Ca,L in KChIP2 Ϫ/Ϫ mice does not result from deficient protein trafficking. Thus, despite an increase in Ca V 1.2 protein, the absence of KChIP2 attenuates I Ca,L in myocytes.
KChIP2 Augments Ca 2؉ Currents in a Heterologous Expression System
The reduced I Ca,L in KChIP2 Ϫ/Ϫ myocytes could be attributable to either loss of a direct modulatory effect on Ca V 1.2 or secondary to unidentified electric remodeling processes that diminish I Ca,L . To distinguish between these possibilities, we tested whether KChIP2 directly modulates I Ca,L in a heterologous expression system. The Ca V 1.2 ␣ 1C subunit and the Ca 2ϩ channel accessory subunits ␤ 2 and ␣ 2 ␦ were expressed with or without KChIP2 in tsA201 cells and whole-cell patch-clamp recordings were compared. Currents from cells expressing KChIP2 showed a Ϸ2-fold increase in peak density ( Figure 2A ) without any change in the activation or steady-state inactivation kinetics ( Figure 2B ). Scaling peak current to unity revealed no effect of KChIP2 coexpression on current decay ( Figure 2C, top) , and pedestal currents measured at 300 ms were comparable between KChIP2-positive and -negative cells ( Figure 2C, bottom) .
As in myocytes, the reduced current density in the absence of KChIP2 could not be attributed to reduced Ca V 1.2 protein expression or decreased trafficking to the plasma membrane: we observed no differences in protein levels with or without KChIP2 coexpression ( Figure 2D ). Furthermore, analysis of GFP-labeled Ca V 1.2 distribution in tsA201 cells showed that membrane targeting of Ca V 1.2 was unaffected by KChIP2 ( Figure 2E ). The membrane/whole-cell GFP fluorescence ratio normalized to cell size was comparable in KChIP2-negative (5.9Ϯ1.6 arbitrary units; nϭ18) and KChIP2-positive cells (5.6Ϯ0.9 arbitrary units, PϾ0.05; nϭ19).
To test specifically for a role for KChIP2 in trafficking Ca V 1.2 to the plasma membrane, we compared currents from cells transfected with Ca V 1.2 (without ␤ 2 ) to cells transfected with Ca V 1.2 and KChIP2. As expected, in the absence of a ␤ 2 subunit, currents were barely detectable (Online Figure II) . The addition of KChIP2 did not generate larger currents, suggesting that KChIP2 cannot replace the role of ␤ subunits in trafficking the pore-forming ␤ subunits to the plasma membrane. Because KChIP2 modulated I Ca,L in a heterologous expression system essentially stripped of all other ionic currents, we conclude that KChIP2 acts directly on the Ca V 1.2 channel.
KChIP2 Affects Ca V 1.2 Currents in a Ca
2؉ -Independent Manner
Next, we determined whether the modulatory effects of KChIP2 are dependent on Ca 2ϩ . When we substituted Ba 2ϩ
for Ca 2ϩ as charge carrier, the addition of KChIP2 still increased current density of Ca V 1.2 channels expressed in tsA201 cells ( Figure 3A ). This suggests that Ca 2ϩ permeation through the channel does not alter KChIP2-mediated effects. To test for a contribution of Ca 2ϩ binding to the KChIP2 EF hands, we constructed a Ca 2ϩ -insensitive KChIP2 with Aspto-Ala mutations in EF hands 2 to 4 KChIP2-⌬EF. 3 Compared to WT-KChIP2, this triple EF-hand mutant produced a Other CaBPs affecting Ca V 1.2 function, like CaM and CaBP1, associate with Ca V 1.2 at the C-and/or the N termini, 14 -17,30 suggesting likely targets for KChIP2 interaction. Hence, we expressed the C and N termini of Ca V 1.2 as fusion proteins tagged with His 6 and GST, respectively, and tested whether they were able to bind KChIP2 in a recombinant bacterial coexpression system. Figure 4A shows a representative Coomassie-stained SDS-PAGE of the proteins purified after affinity chromatography: KChIP2 copurifies with the region of the N terminus previously shown to support CaM binding (amino acids 60 to 120; 17 ) but not with GST alone. A construct with amino acids 1 to 70 of Ca V 1.2 showed no KChIP2 copurification (data not shown). In contrast, KChIP2 did not interact with the Ca V 1.2 C terminus. The C-terminal domain of Ca V 1.2 cannot be purified as a soluble protein in the absence of a true binding partner, 31 and we did not recover any soluble Ca V 1.2 C terminus when KChIP2 was coexpressed ( Figure 4A ). In contrast, the Ca V 1.2 C-terminal domain was purified when CaM was coexpressed as a binding partner. Thus, KChIP2 likely mediates its effect on I Ca,L through an interaction with the Ca V 1.2 N terminus.
To address the importance of the calcium-binding properties of KChIP2, we repeated the copurification experiments when To confirm functionally that KChIP2 modulates Ca V 1.2 through its interaction with the ␣ 1C N terminus, we deleted the first 139 aa of ␣ 1C (⌬NT-Ca V 1.2) and tested this truncated channel in patch-clamp experiments. The current recorded from the ⌬NT-Ca V 1.2 construct in the absence of KChIP2 was increased Ϸ3-fold compared to WT-Ca V 1.2 ( Figure 4B ), as previously reported. 32 The increased current density seen with the ⌬NT-Ca V 1.2 construct relative to WT-Ca V 1.2 was not secondary to changes in protein levels of Ca V 1.2 ( Figure 4C ), consistent with pervious results. 32, 33 With its binding site in the Ca V 1.2 N terminus now absent, KChIP2 no longer produced an increase in I Ca,L current density ( Figure 4B ). These data suggest that KChIP2 affects I Ca,L through a direct association with the N-terminal domain of Ca V 1.2. Because these heterologous expression systems contain ␤ and ␣ 2 ␦ subunits, we cannot formally exclude the possibility that KChIP2 interactions with these auxiliary subunits contribute to the observed modulation.
Discussion
The novel findings in this study are that KChIP2 modulates I Ca,L by interacting with the N-terminal domain of Ca V 1.2 and does so in a Ca 2ϩ -independent manner. Moreover, this modulation increases I Ca,L amplitude without requiring additional Ca V 1.2 channel protein.
Generally, amplitudes of ionic currents can be augmented by adding functional ion channels to the sarcolemma (N), by increasing the likelihood of the channel to be in the open state (P O ), or by improving conductance of the individual channel (i). Although the present study did not determine which (combination) of these 3 mechanisms was underlying the KChIP2-mediated increase in whole-cell Ca 2ϩ current amplitude, the unaltered protein expression ( Figure 2D ) and localization ( Figure 2E ) make it unlikely that the KChIP2-mediated increase in amplitude derives from improved trafficking of functional channels to the membrane. Consistent with this logic, subcellular fractions from WT myocytes actually had lower levels of Ca V 1.2 protein than KChIP2 Ϫ/Ϫ myocytes ( Figure 1D ) even though current amplitude was higher in the WT myocytes.
Instead of affecting the parameter N, we propose a model in which KChIP2 association with Ca V 1.2 increases P O by relieving the inhibitory effects of the ␣ 1C N terminus that have previously been characterized by Dascal and colleagues. 16, 33 As described, ␣ 1C contains a NTI module 34 that decreases the channel's maximal open probability (P O,max ), in a manner that is partially relieved by the ␤ subunit. 33 We propose that KChIP2 interacts with the ␣ 1C N terminus, reducing the effect of the NTI module on channel gating beyond that provided by the ␤ subunit ( Figure 5 ). Consistent with this hypothesis, KChIP2 binding to the N-terminal domain was established both biochemically ( Figure 4A ) and functionally ( Figure 4B ). Furthermore, KChIP2 caused an increased current density in the absence of a shift in the activation curve ( Figure 2B ), consistent with modulation of the NTI module. 33 Finally, KChIP2 did not increase Ca V 1.2 current density in the absence of the ␤ subunit (Online Figure  II) , also consistent with an action on P O,max rather than an effect on channel trafficking; however, this hypothesis must be verified by single-channel recordings.
As a member of the CaBP family, KChIP2 is the newest example of a CaBP that regulates voltage-gated Ca 2ϩ channels in general and Ca V 1.2 channels in particular. KChIP2 is unique among these CaBPs, however, in that Ca 2ϩ binding does not appear to be required for dynamic regulation of Ca 2ϩ channel function: we observed comparable KChIP2 influence of I Ba ( Figure 3A ) and no change in I Ca amplitude when the Ca 2ϩ -binding EF hands of KChIP2 were mutated ( Figure  3B ). Furthermore, KChIP2 copurified with the N terminus both in the presence and in the absence of free Ca 2ϩ . The Ca 2ϩ -insensitive KChIP2-⌬EF mutant also binds to Kv4.2 but does not modulate the K ϩ current, 3 suggesting distinct Ca 2ϩ -dependent and -independent regulatory functions of KChIP2. Nonetheless, the depolarizing shift in the activation Ϫ/Ϫ myocytes is not known but, if correct, would indicate that KChIP2 modulates Ca V 1.2 currents via multiple and independent mechanisms and would place more emphasis on the additional roles attributed to KChIP2, such as the modulation and regulation of cardiac Na V and K V currents. 3, 6, 23 Thus, KChIP2 appears to be a multimodal regulator of several cardiac ionic currents rather than a contributor solely to I to .
The Ca V 1.2 gene gives rise to multiple, tissue-specific isoforms as a consequence of alternative splicing. The NTI module is absent in short N-terminal isoforms, in which the initial 46 aa encoded by exon 1a are replaced by a partially homologous sequence of 16 amino acids encoded by exon 1b. 33 Whereas the long isoforms containing the NTI module are predominant in the heart, vascular smooth muscle cells express only the short isoforms lacking the NTI module. 36 Both short and long N-terminal isoforms are found in the brain. At present, it is unknown whether KChIP2 interacts with Ca V 1.2 isoforms lacking the NTI module; however, such association would have implications for Ca 2ϩ entry in vascular tissue and in neuronal tissue-expressing KChIP2.
Our findings may have even more relevance to arrhythmogenesis. Initially described as an auxiliary subunit for the neuronal A-type current, 3 KChIP2 was later shown to be important for the expression of I to in the human heart. 5 Recently, it was reported that posttranscriptional silencing of KChIP2 decreases I to and I Na , suggesting that the 2 channels form a structural and functional channel complex. 23 The present data show that KChIP2, in addition to its other regulatory functions, modulates the cardiac Ca 2ϩ current, implicating a broad physiological role of KChIP2 in cardiac electrophysiology. Although the arrhythmia susceptibility of KChIP2 Ϫ/Ϫ knockout mice 23 already pointed to a key physiological role for KChIP2, the data reported here offer new hypotheses about the observed arrhythmogenesis. This concept is particularly relevant because mice lacking the subunit for the I to current (K V 4.2) showed no arrhythmia susceptibility 37 ; likely one of the other modulatory roles played by KChIP2 is paramount.
Our findings also suggest a role for KChIP2 in arrhythmogenesis associated with heart failure. Because KChIP2 is downregulated in patients with heart failure, 38 the present findings in combination with the previous reports of KChIP2-mediated actions of K V and Na V currents, 3, 23 suggest that KChIP2-downregulation will have widespread effects on electrophysiology and contractile performance. Our results specifically predict that KChIP2 downregulation would decrease I Ca,L , thereby highlighting a recent report in which loss-of-function mutations in the Ca V 1.2 ␣ 1C or the ␤ 2 subunits are associated with sudden cardiac death. 39 Of particular interest, one of the mutations reported in that study, A39V in ␣ 1C , resides in the N terminus of ␣ 1C . It is reasonable to speculate that the reduced current observed in cells expressing the A39V mutant results from an effect on the ␣ 1C NTI module. It is also intriguing that a common ECG phenotype reported for these patients with I Ca,L loss of function was J-point elevation: as previously observed 24 and as confirmed by us (Online Figure I and Online Table I ), ECGs from KChIP2 Ϫ/Ϫ mice also display J-point elevation. This may be secondary to effects on I Ca,L rather than on I to , as suggested by a report in which ECGs from Kv4.2 Ϫ/Ϫ mice are indistinguishable from WT. 37 
Conclusion
These data provide new insights into the function of the cardiac Ca V 1.2 calcium channel. The effects of KChIP2 on I Ca,L in both native myocytes and in heterologous expression systems strongly suggest that this protein directly augments current amplitude in the absence of altered channel density, activation or inactivation kinetics. Our data, taken together with previous studies, suggest that KChIP2 is a multimodal regulator of a range of voltage-gated cardiac K ϩ , Na ϩ , and Ca 2ϩ channels.
